Latest Breaking News On - Mateon therapeutics - Page 9 : comparemela.com

Reven Holdings Announces the Launch of Its Translational Oncology Program: Targeting Tumor Microenvironment to Improve Treatment Outcomes in Cancer

MATEON'S UPDATE ON C001 - GLOBAL STUDY FOR OT-101 AGAINST COVID-19

Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution

Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution 08 March 2021 | News Source credit: Shutterstock Gurugram based Windlas Biotech, in partnership with Mateon Therapeutics in the US, has launched an innovative drug-device therapy PulmoHeal + ARTIHealth as a complete respiratory wellness solution. In a first, the AI-app based platform ARTIHealth™, developed by Mateon Therapeutics will enable patients to monitor the progress of their respiratory function over time by enabling them to upload daily cough and speech recording and receiving feedback on the health of their lungs. The platform is a self-assessment and monitoring tool that provides >90 per cent accurate feedback used for suitable self-care and remote healthcare. This is part of a long-term joint development agreement with IBM Watson Health Research and Mateon. 

Windlas Biotech, Mateon Therapeutics partner to launch lung therapy solution

Windlas Biotech, Mateon Therapeutics partner to launch lung therapy solution February 22, 2021 × Developed from Artemisia extract, the active component of PulmoHeal has been known to exhibit multiple pharmacological activities against inflammation, viral infections, and lung repair. Windlas Biotech Pvt. Ltd., an Indian pharmaceutical contract drug development and manufacturing organisation partnered with Mateon Therapeutics, Inc., a US-based oncology company, launched a food supplement, and telemedicine support for respiratory wellness in India. According to the joint official release, in India, around 100 million people suffer from respiratory problems. The key challenges are the lack of cost-effective and lab-free methods for the early diagnosis of diseases.

Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India

The product, PulmoHeal™ is a broad-spectrum, lung therapy food supplement that is supported by a multi-centre rigorous clinical study and integrated with its own telemedicine AI based platform to offer continuous 360 care for patients in India. Developed from extract of the indigenous plant Artemisia, the active component of PulmoHealTM, Artemisinin, has been known to exhibit multiple pharmacological activity against inflammation, viral infections, and lung repair